RecruitingPhase 3NCT06012240
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Studying Alopecia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- AbbVie
- Principal Investigator
- ABBVIE INC.AbbVie
- Intervention
- Upadacitinib(drug)
- Enrollment
- 1500 target
- Eligibility
- 12-63 years · All sexes
- Timeline
- 2023 – 2028
Study locations (30)
- Total Skin and Beauty Dermatology Center /ID# 259539, Birmingham, Alabama, United States
- Duplicate_Advanced Research Associates - Glendale /ID# 259108, Glendale, Arizona, United States
- Southwest Skin Specialists /ID# 258234, Phoenix, Arizona, United States
- Alliance Dermatology and Mohs Center /ID# 258111, Phoenix, Arizona, United States
- Johnson Dermatology Clinic /ID# 259103, Fort Smith, Arkansas, United States
- Duplicate_JOSEPH RAOOF MD,INC /ID# 258031, Encino, California, United States
- First OC Dermatology /ID# 259220, Fountain Valley, California, United States
- University of California Irvine /ID# 259096, Irvine, California, United States
- Dermatology Research Associates /ID# 258033, Los Angeles, California, United States
- Stanford University School of Medicine - Redwood City /ID# 259542, Redwood City, California, United States
- Integrative Skin Science and Research /ID# 258114, Sacramento, California, United States
- University of California Davis Health /ID# 258112, Sacramento, California, United States
- Clinical Trials Research Institute /ID# 258021, Thousand Oaks, California, United States
- Skin Care Research Boca Raton /ID# 258012, Boca Raton, Florida, United States
- Apex Clinical Trials /ID# 259205, Brandon, Florida, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06012240 on ClinicalTrials.govOther trials for Alopecia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07533006A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)Eli Lilly and Company
- ENROLLING BY INVITATIONNCT07499713Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataIstanbul Training and Research Hospital
- RECRUITINGPHASE3NCT07435012Androgenic Alopecia TH07 Clinical TrialTriple Hair Inc
- RECRUITINGNANCT07422376Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands RegionCharles Mays
- RECRUITINGNCT07226531Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USPfizer
- RECRUITINGNANCT07563036JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilKasr El Aini Hospital
- RECRUITINGPHASE2NCT07370519Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaShenzhen People's Hospital
- ACTIVE NOT RECRUITINGNANCT07520019Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning HairNutra Harmony LLC